Neuronetics CEO files initial Form 3

Neuronetics, Inc. filed an initial insider ownership report for President and CEO Daniel L. Reuvers.

Accepted by SEC EDGAR 03/23/2026 - 04:38 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Neuronetics, Inc. filed an initial insider ownership report for President and CEO Daniel L. Reuvers. This Form 3 identifies him as an executive officer but does not show any stock transactions or option exercises. It serves as a baseline disclosure of his status as a reporting insider under SEC rules.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Neuronetics (STIM) Form 3 for Daniel L. Reuvers show?

The Form 3 identifies Daniel L. Reuvers as President and CEO of Neuronetics and a reporting insider. It does not list any stock transactions or derivative exercises, serving mainly as a baseline ownership and status disclosure under SEC requirements.

Does the Neuronetics (STIM) Form 3 report any insider buying or selling?

The Form 3 reports no insider buying or selling by Daniel L. Reuvers. Transaction counts and share amounts for purchases, sales, gifts, tax withholdings, and restructurings are all zero, indicating no trading activity is disclosed in this filing.

Who is the reporting person in the Neuronetics (STIM) Form 3 filing?

The reporting person is Daniel L. Reuvers, President and CEO of Neuronetics, Inc. The filing confirms his officer status and title, which makes him subject to ongoing insider reporting obligations on Forms 4 and 5 for future transactions in company securities.

What is the purpose of this Neuronetics (STIM) Form 3 with no transactions?

This Form 3 establishes Daniel L. Reuvers as a reporting insider without detailing trades. It functions as an initial statement of beneficial ownership status, enabling the SEC and investors to track any future reportable activities in Neuronetics securities by this executive.

Does the Neuronetics (STIM) Form 3 disclose any derivative positions or options?

The Form 3 derivative summary is empty, showing no listed options, warrants, or other derivative positions for Daniel L. Reuvers. Exercise-related metrics, such as exercise count and exercise shares, are also zero, indicating no derivative activity is reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

REUVERS DANIEL L.

(Last)

(First)

(Middle)

C/O NEURONETICS, INC.

3222 PHOENIXVILLE PIKE

(Street)

MALVERN

PENNSYLVANIA

19355

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/23/2026

3. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

No securities are beneficially owned.

	/s/ Patrick Devine, as Attorney-in-Fact	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR